Endocrinology billing looks deceptively straightforward until you look at what it actually involves. (Endocrinology Medical Billing Company)
Diabetes management alone spans more than 70 distinct ICD-10 codes depending on type, complication, and severity. Continuous glucose monitoring (CGM) and insulin pump billing require device-specific HCPCS codes, payer-specific coverage criteria, and ongoing supply billing that most practices either miss entirely or submit incorrectly. Thyroid procedures, adrenal workups, bone density studies, and hormone management visits all carry their own coding requirements, prior authorization rules, and documentation standards.
Add in the chronic care complexity of a patient panel that frequently includes diabetes, thyroid disease, obesity, and adrenal disorders simultaneously and you have a billing environment where E/M undercoding, missed device management revenue, and ICD-10 specificity errors compound into significant monthly revenue gaps.
At Malakos Healthcare Solutions, we provide specialized endocrinology billing services built around the full scope of what endocrinology practices deliver from highly specific diabetes coding and CGM billing to thyroid procedure codes, hormone panel interpretation, and chronic care management. Accurate coding, proactive authorization management, and full revenue cycle visibility so your practice gets paid correctly for the complexity of care it provides.
Why Endocrinology Billing Requires Specialty Expertise
Diabetes Coding Is the Most Specificity-Dependent Coding in Outpatient Medicine
Diabetes ICD-10 coding is not a single code it is a structured system of primary and secondary codes that must reflect type, complications, severity, and associated conditions with precision. Using E11.9 (Type 2 diabetes, unspecified) for a patient with documented diabetic peripheral neuropathy is undercoding. Billing E11.65 without the corresponding secondary code for hyperglycemia is incomplete. Failing to capture the complication-specific code means the documentation doesn’t support the complexity of care and the E/M level that complexity justifies.
Getting diabetes coding right is the foundation of endocrinology revenue cycle management. It directly affects E/M level justification, medical necessity determination for associated tests and procedures, and chronic care management billing eligibility.
CGM and Insulin Pump Billing Is a Separate Revenue Stream Most Practices Don’t Capture Correctly
Continuous glucose monitoring and insulin pump therapy generate ongoing billable services initial device coding, ongoing supply billing, and professional interpretation of CGM data that are distinct from the office visit coding. Most endocrinology practices either don’t bill these services at all, bill them under incorrect codes, or fail to meet payer-specific coverage criteria documentation requirements.
For a practice managing 100+ active CGM or insulin pump patients, this represents a material and recurring monthly revenue gap.
E/M Visits Are Systematically Undercoded for Chronic Endocrine Disease Complexity
Endocrinology visits frequently involve: managing multiple chronic conditions simultaneously (diabetes + thyroid disease + obesity + metabolic syndrome), reviewing and interpreting lab panels, adjusting complex medication regimens with monitoring requirements, reviewing CGM or insulin pump download data, and coordinating care with primary care and specialists. Under 2021 AMA E/M guidelines, this level of complexity routinely supports 99214 or 99215 but most endocrinology practices default to 99213 for established patients regardless of visit content.
Prior Authorization Is Required for High-Value Endocrinology Services
CGM devices, insulin pumps, advanced hormone testing panels, DEXA scans, thyroid ultrasounds, and specialty medications (GLP-1 agonists, injectable osteoporosis agents) all commonly require prior authorization. Authorization gaps result in expensive services rendered without coverage and unlike a routine office visit, a denied DEXA or a denied CGM device represents significant revenue at risk.
Endocrinology CPT Codes Complete Reference by Service Category
Evaluation and Management Endocrinology Office Visits
E/M visits are the highest-volume billing category in most endocrinology practices. Under 2021 AMA guidelines, level is selected based on medical decision-making complexity or total time not exam components.
| CPT Code | Patient Type | MDM Complexity | Typical Time | Endocrinology Clinical Context |
|---|---|---|---|---|
| 99202 | New patient | Straightforward | 15-29 min | Rarely appropriate in endocrinology most new patients present with chronic or complex conditions |
| 99203 | New patient | Low | 30-44 min | New patient with single stable endocrine condition; prescription required |
| 99204 | New patient | Moderate | 45-59 min | New patient with diabetes or thyroid disease requiring management; new problem with diagnostic workup |
| 99205 | New patient | High | 60-74 min | New patient with multiple endocrine conditions; complex medication initiation; severe presentation |
| 99212 | Established patient | Straightforward | 10-19 min | Stable single condition; routine prescription refill; no changes |
| 99213 | Established patient | Low | 20-29 min | Single stable chronic condition with minor adjustment |
| 99214 | Established patient | Moderate | 30-39 min | One or more chronic conditions with exacerbation; prescription drug management; review of diagnostic tests; CGM data interpretation |
| 99215 | Established patient | High | 40-54 min | Severe or poorly controlled endocrine disease; multiple complex conditions; high-risk medication management |
Critical E/M guidance for endocrinology:
- Managing diabetes with complications (neuropathy, nephropathy, retinopathy) is not straightforward MDM it is moderate to high complexity. A visit where the provider reviews CGM data, adjusts insulin dosing, documents active complications, and orders follow-up labs routinely supports 99214.
- Reviewing and interpreting a diagnostic test result HbA1c trend, thyroid function panel, adrenal hormone levels as an independent data point contributes to MDM data complexity, supporting higher E/M levels.
- Managing two or more chronic conditions (diabetes + hypothyroidism + obesity) simultaneously meets the threshold for moderate complexity MDM (99214) under current AMA guidelines.
- Prescription drug management with monitoring requirements insulin titration, thyroid hormone dosing, steroid tapering contributes to MDM risk and supports 99214 or 99215.
Continuous Glucose Monitoring (CGM) Billing
CGM billing is one of the most consistently underbilled and incorrectly billed service categories in endocrinology. It involves three distinct billing components: the device itself, ongoing supplies, and professional data interpretation.
CGM Professional Services (Physician/NP Interpretation)
| CPT Code | Description | Notes |
|---|---|---|
| 95250 | Ambulatory continuous glucose monitoring of interstitial tissue fluid physician-provided equipment, sensor placement, hook-up, calibration of monitor, patient training, removal of sensor, and printout of recording | Used when practice provides the CGM equipment and supervises the setup |
| 95251 | Ambulatory CGM of interstitial tissue fluid interpretation and report | Physician/NP professional interpretation of CGM data download; separately billable per interpretation session |
Payer notes on CGM professional services:
- Medicare covers CGM devices for patients with diabetes who require frequent insulin adjustments specific coverage criteria apply
- 95251 can be billed for each CGM data download review session separate from the office visit if a distinct interpretation report is generated
- When CGM data is reviewed and interpreted during an office visit as part of the E/M service, 95251 may or may not be separately billable depending on payer verify before billing both
CGM Devices and Supplies (HCPCS – Durable Medical Equipment)
| HCPCS Code | Description | Coverage Notes |
|---|---|---|
| A9276 | CGM sensor each | Per-sensor billing for CGM supply refills |
| A9277 | CGM transmitter | Transmitter replacement billing |
| A9278 | CGM receiver | Receiver/reader device billing |
| K0553 | Supply allowance for therapeutic CGM device Type 1 | Medicare-specific; therapeutic CGM (real-time, used for treatment decisions) |
| K0554 | Receiver for therapeutic CGM device | Medicare-specific |
Medicare CGM coverage criteria (as of current guidance):
- Patient has diabetes mellitus
- Patient is insulin-treated (basal insulin, multiple daily injections, or insulin pump)
- Treating physician/NP has a face-to-face visit with the patient within 6 months prior to ordering
- CGM is prescribed as part of the diabetes management plan
- Device must be considered a therapeutic CGM (not adjunctive) under current Medicare coverage determinations
Insulin Pump (CSII) Billing
Insulin pump therapy generates initial device billing, ongoing supply billing, and professional management codes a complete recurring revenue stream that most billing teams don’t manage systematically.
Insulin Pump Devices and Supplies (HCPCS)
| HCPCS Code | Description | Notes |
|---|---|---|
| E0784 | External ambulatory infusion pump, insulin | Insulin pump device; requires prior auth from virtually all payers |
| A9274 | External ambulatory infusion pump, insulin, per 3-month supply | Supply billing for insulin pump consumables |
| A4224 | Supplies for maintenance of insulin infusion catheter | Infusion sets and reservoirs |
| A4225 | Supplies for external insulin infusion pump, syringe type | |
| A4226 | Supplies for external insulin infusion pump, non-needle cannula type | |
| A4230 | Infusion set for external insulin pump, non-needle cannula type | Per infusion set |
| A4231 | Infusion set for external insulin pump, needle type | |
| A4232 | Syringe with needle for insulin pump |
Insulin Pump Professional Management
| CPT Code | Description | Notes |
|---|---|---|
| 95249 | Ambulatory CGM of interstitial tissue fluid patient-provided equipment, physician analysis; includes interpretation and report | For practices interpreting data from patient-owned CGM/pump systems |
| 99213–99215 | E/M for insulin pump management visit | Pump downloads, basal rate adjustments, carb ratio review document MDM complexity for level selection |
Prior authorization for insulin pumps: Most commercial payers require documentation of: Type 1 diabetes or insulin-dependent Type 2, history of frequent hypoglycemia or hypoglycemia unawareness, current multiple daily injection regimen with HbA1c documentation, and provider attestation. Authorization is required for the pump and separately for ongoing supplies at most payers.
Thyroid Services
Thyroid disorders are the second most common condition in endocrinology after diabetes. Billing for thyroid-related services spans E/M visits, imaging, and procedures.
| CPT Code | Description | Notes |
|---|---|---|
| 76536 | Ultrasound, soft tissue of head and neck real time with image documentation | Thyroid ultrasound; requires separate interpretation report in chart |
| 76942 | Ultrasonic guidance for needle placement with imaging supervision and interpretation | Used when ultrasound guidance is applied during thyroid biopsy; permanent image record required |
| 60100 | Biopsy, thyroid | Core needle biopsy of thyroid |
| 10005 | Fine needle aspiration biopsy first lesion, ultrasound guidance | FNA thyroid with ultrasound guidance most common thyroid biopsy approach |
| 10006 | FNA biopsy each additional lesion, ultrasound guidance | Add-on for additional nodule |
| 88172 | Cytopathology evaluation immediate cytohistologic study | Rapid on-site evaluation (ROSE) during thyroid FNA |
| 88173 | Cytopathology interpretation FNA smears | Interpretation of thyroid FNA specimens |
| 78012 | Thyroid uptake, single or multiple quantitative measurement | Nuclear medicine thyroid uptake |
| 78013 | Thyroid imaging with uptake single determination | |
| 78014 | Thyroid imaging with uptake multiple determinations | |
| 78015 | Thyroid carcinoma metastases imaging limited area | Post-thyroidectomy surveillance scan |
| 78016 | Thyroid carcinoma metastases imaging multiple areas | |
| 78018 | Thyroid carcinoma metastases imaging whole body | |
| 78070 | Parathyroid imaging planar | |
| 78071 | Parathyroid imaging with subtraction |
Payer notes on thyroid imaging:
- Thyroid ultrasound (76536) frequently requires prior authorization when ordered for nodule surveillance verify payer-specific criteria
- FNA with ultrasound guidance requires documentation of the specific nodule characteristics (size, composition, ACR TI-RADS category) to support medical necessity
- Thyroid cancer surveillance scans (78015-78018) require prior auth and documentation of thyroidectomy history and TSH suppression status
Bone Density and Osteoporosis
DEXA scanning is a high-value service in endocrinology that requires specific CPT code selection based on anatomy scanned and payer-specific frequency limitations.
| CPT Code | Description | Notes |
|---|---|---|
| 77080 | DXA bone density – axial skeleton (hip, pelvis, spine) | Most commonly performed DEXA; requires prior auth from many payers |
| 77081 | DXA bone density – appendicular skeleton (radius, wrist, heel) | Peripheral DEXA; covered differently than axial |
| 77085 | DXA bone density – axial and vertebral fracture assessment | Combined DEXA with VFA; increasingly required for osteoporosis risk stratification |
| 77086 | Vertebral fracture assessment (VFA) via dual-energy X-ray absorptiometry | VFA as standalone when axial DEXA already performed |
Medicare DEXA coverage rules:
- Medicare covers axial DEXA every 24 months for qualifying patients (estrogen-deficient women at clinical risk, vertebral abnormality, long-term glucocorticoid therapy, primary hyperparathyroidism, on osteoporosis therapy monitoring)
- Billing DEXA more frequently than every 24 months without documented clinical exception is a Medicare compliance risk
- Document the qualifying indication on every DEXA order and claim
Adrenal and Pituitary Procedures
| CPT Code | Description | Notes |
|---|---|---|
| 74178 | CT abdomen and pelvis with contrast | Adrenal mass characterization; requires radiology |
| 70553 | MRI brain with and without contrast | Pituitary adenoma evaluation |
| 70551 | MRI brain without contrast | |
| 93000 | ECG with interpretation | Frequently performed in endocrinology for metabolic syndrome/cardiovascular risk assessment |
| 36415 | Routine venipuncture | |
| 80048 | Basic metabolic panel | |
| 80053 | Comprehensive metabolic panel | |
| 82607 | Vitamin B12 | |
| 82306 | Vitamin D, 25-hydroxyvitamin D | Frequently ordered; document clinical indication |
| 84443 | TSH | Most common endocrine lab test |
| 84436 | Thyroxine (T4), total | |
| 84439 | Thyroxine (T4), free | |
| 84480 | T3, total | |
| 84481 | T3, free | |
| 84432 | Thyroglobulin | Thyroid cancer surveillance |
| 86800 | Thyroid antibodies, TPO | |
| 82533 | Cortisol, total | |
| 82530 | Cortisol, free | |
| 82670 | Estradiol | |
| 83519 | Immunoassay for analyte other than antibody quantitative | Used for many endocrine hormone panels |
| 83001 | Gonadotropin, follicle stimulating hormone (FSH) | |
| 83002 | Gonadotropin, luteinizing hormone (LH) | |
| 84146 | Prolactin | |
| 83036 | Hemoglobin A1c | Most commonly ordered endocrinology lab |
| 82947 | Glucose, quantitative | |
| 82950 | Glucose, post-glucose dose | |
| 82951 | Glucose tolerance test 3 specimens | |
| 83525 | Insulin, total | |
| 83527 | Insulin, free | |
| 84403 | Testosterone, total | |
| 84402 | Testosterone, free | |
| 82088 | Aldosterone | |
| 82383 | Catecholamines plasma | Pheochromocytoma workup |
| 82384 | Catecholamines fractionated | |
| 83835 | Metanephrines | |
| 84585 | Urine vanillylmandelic acid (VMA) |
Chronic Care Management (CCM) in Endocrinology
Endocrinology practices particularly those with large diabetes and thyroid disease patient panels — have significant monthly CCM billing opportunity that most are not capturing.
| CPT Code | Description | Time | Requirement |
|---|---|---|---|
| 99490 | CCM clinical staff, first 20 min/month | 20 min | Two or more chronic conditions; written consent; care plan |
| 99439 | CCM clinical staff, each additional 20 min | +20 min | Add-on |
| 99491 | CCM physician/NP personal time, first 30 min/month | 30 min | When provider personally performs CCM |
| 99437 | CCM each additional 30 min | +30 min | Add-on |
| 99487 | Complex CCM first 60 min/month | 60 min | Moderate or high complexity MDM; multiple complex conditions |
| 99489 | Complex CCM each additional 30 min | +30 min | Add-on |
Endocrinology CCM opportunity: A patient with Type 2 diabetes + hypothyroidism + obesity three chronic conditions qualifies for CCM. A patient with Type 1 diabetes on insulin pump therapy who requires monthly care coordination qualifies for complex CCM (99487). Most endocrinology practices with Medicare panels are leaving hundreds of qualifying CCM billing opportunities uncaptured every month.
Diabetes Prevention and Self-Management Education
| CPT/HCPCS Code | Description | Notes |
|---|---|---|
| G0108 | Diabetes self-management training individual | Medicare-covered DSMT; requires physician referral and ADA-recognized program |
| G0109 | Diabetes self-management training group | 2+ patients simultaneously |
| 97802 | Medical nutrition therapy initial individual, 15 min | MNT for diabetes; covered by Medicare with physician referral |
| 97803 | MNT reassessment, individual, 15 min | Follow-up MNT sessions |
| 99401–99404 | Preventive counseling individual, 15–60 min | Obesity and lifestyle counseling |
| G0447 | Behavioral counseling for obesity face-to-face, 15 min | Medicare-covered; BMI ≥30 required |
DSMT billing rules:
- Medicare covers up to 10 hours of DSMT in the first year and 2 hours annually thereafter
- Must be provided by an ADA-recognized or AADE-accredited program
- Requires a physician referral with the diabetes diagnosis documented
- DSMT and MNT can both be billed in the same benefit year they are not mutually exclusive
ICD-10 Codes for Endocrinology — Complete Reference
ICD-10 coding specificity is the single most important documentation-to-billing alignment issue in endocrinology. The diabetes ICD-10 system is a structured coding framework not a list of interchangeable codes. Choosing the wrong level of specificity directly affects medical necessity determinations, E/M level justification, and authorization outcomes.
Diabetes Mellitus – Type 1
| ICD-10 | Description |
|---|---|
| E10.9 | Type 1 diabetes mellitus without complications |
| E10.10 | Type 1 diabetes with ketoacidosis, without coma |
| E10.11 | Type 1 diabetes with ketoacidosis, with coma |
| E10.21 | Type 1 diabetes with diabetic nephropathy |
| E10.22 | Type 1 diabetes with diabetic chronic kidney disease, stage 1–2 |
| E10.29 | Type 1 diabetes with other diabetic kidney complication |
| E10.311 | Type 1 diabetes with unspecified diabetic retinopathy, with macular edema |
| E10.319 | Type 1 diabetes with unspecified diabetic retinopathy, without macular edema |
| E10.40 | Type 1 diabetes with diabetic neuropathy, unspecified |
| E10.41 | Type 1 diabetes with diabetic mononeuropathy |
| E10.43 | Type 1 diabetes with diabetic autonomic neuropathy |
| E10.49 | Type 1 diabetes with other diabetic neurological complication |
| E10.51 | Type 1 diabetes with diabetic peripheral angiopathy without gangrene |
| E10.52 | Type 1 diabetes with diabetic peripheral angiopathy with gangrene |
| E10.610 | Type 1 diabetes with diabetic neuropathic arthropathy |
| E10.618 | Type 1 diabetes with other diabetic arthropathy |
| E10.65 | Type 1 diabetes with hyperglycemia |
| E10.649 | Type 1 diabetes with hypoglycemia without coma |
| E10.641 | Type 1 diabetes with hypoglycemia with coma |
Diabetes Mellitus – Type 2
| ICD-10 | Description |
|---|---|
| E11.9 | Type 2 diabetes mellitus without complications |
| E11.00 | Type 2 diabetes with hyperosmolarity, without nonketotic hyperglycemic-hyperosmolar coma |
| E11.10 | Type 2 diabetes with ketoacidosis, without coma |
| E11.21 | Type 2 diabetes with diabetic nephropathy |
| E11.22 | Type 2 diabetes with diabetic chronic kidney disease, stage 1–2 |
| E11.311 | Type 2 diabetes with unspecified diabetic retinopathy, with macular edema |
| E11.319 | Type 2 diabetes with unspecified diabetic retinopathy, without macular edema |
| E11.40 | Type 2 diabetes with diabetic neuropathy, unspecified |
| E11.43 | Type 2 diabetes with diabetic autonomic (poly)neuropathy |
| E11.49 | Type 2 diabetes with other diabetic neurological complication |
| E11.51 | Type 2 diabetes with diabetic peripheral angiopathy without gangrene |
| E11.610 | Type 2 diabetes with diabetic neuropathic arthropathy |
| E11.65 | Type 2 diabetes with hyperglycemia |
| E11.649 | Type 2 diabetes with hypoglycemia without coma |
| Z79.4 | Long-term current use of insulin |
Critical coding rule – Z79.4: When a Type 2 diabetes patient uses insulin (not just oral agents), Z79.4 must be added as a secondary code on every claim. Failing to include Z79.4 when a Type 2 patient is on insulin is one of the most common ICD-10 errors in endocrinology and affects CGM and insulin pump coverage determinations.
Other Diabetes Types
| ICD-10 | Description |
|---|---|
| E08.x | Diabetes mellitus due to underlying condition |
| E09.x | Drug or chemical induced diabetes mellitus |
| E13.x | Other specified diabetes mellitus |
| O24.410 | Gestational diabetes in pregnancy, diet controlled |
| O24.414 | Gestational diabetes in pregnancy, insulin controlled |
| O24.419 | Gestational diabetes in pregnancy, unspecified control |
Thyroid Disorders
| ICD-10 | Description |
|---|---|
| E03.9 | Hypothyroidism, unspecified |
| E03.0 | Congenital hypothyroidism with diffuse goiter |
| E05.00 | Thyrotoxicosis with diffuse goiter, without thyrotoxic crisis |
| E05.01 | Thyrotoxicosis with diffuse goiter, with thyrotoxic crisis |
| E05.10 | Thyrotoxicosis with toxic single thyroid nodule, without crisis |
| E05.20 | Thyrotoxicosis with toxic multinodular goiter, without crisis |
| E06.3 | Autoimmune thyroiditis (Hashimoto’s) |
| E04.1 | Nontoxic single thyroid nodule |
| E04.2 | Nontoxic multinodular goiter |
| C73 | Malignant neoplasm of thyroid gland |
| Z85.850 | Personal history of malignant neoplasm of thyroid |
| Z79.899 | Other long-term medication use (levothyroxine — use when applicable) |
Adrenal, Pituitary, and Other Endocrine Disorders
| ICD-10 | Description |
|---|---|
| E27.1 | Primary adrenocortical insufficiency (Addison’s disease) |
| E27.40 | Corticoadrenal insufficiency, unspecified |
| E24.0 | Pituitary-dependent Cushing’s disease |
| E24.2 | Pseudo-Cushing’s syndrome, alcohol-induced |
| E22.0 | Acromegaly and pituitary gigantism |
| E22.1 | Hyperprolactinemia |
| E23.0 | Hypopituitarism |
| E34.0 | Carcinoid syndrome |
| D35.00 | Benign neoplasm of adrenal gland, unspecified |
| E20.0 | Idiopathic hypoparathyroidism |
| E21.0 | Primary hyperparathyroidism |
| E21.3 | Hyperparathyroidism, unspecified |
| E28.2 | Polycystic ovarian syndrome (PCOS) |
| E29.1 | Testicular hypofunction |
| E31.0 | Autoimmune polyglandular failure |
Obesity and Metabolic Disorders
| ICD-10 | Description |
|---|---|
| E66.01 | Morbid (severe) obesity due to excess calories |
| E66.09 | Other obesity |
| E66.1 | Drug-induced obesity |
| E78.00 | Pure hypercholesterolemia, unspecified |
| E78.5 | Hyperlipidemia, unspecified |
| E83.51 | Hypocalcemia |
| E83.52 | Hypercalcemia |
| E87.1 | Hypo-osmolality and hyponatremia |
| E87.5 | Hyperkalemia |
| Z68.x | Body mass index |
Osteoporosis and Bone Disorders
| ICD-10 | Description |
|---|---|
| M81.0 | Age-related osteoporosis without current pathological fracture |
| M80.00 | Age-related osteoporosis with current pathological fracture, unspecified site |
| M85.80 | Other specified disorders of bone density, unspecified site |
| Z87.310 | Personal history of osteoporosis |
Modifier Reference for Endocrinology Billing
| Modifier | When to Use | Pitfall if Missing |
|---|---|---|
| 25 | Significant, separately identifiable E/M on same day as a procedure (e.g., thyroid ultrasound, DEXA, CGM setup) | E/M bundled into procedure; paid at zero |
| 59 | Distinct procedural service two services that would otherwise be bundled are genuinely separate | Secondary service denied or zero-paid |
| TC | Technical component only facility performing imaging without professional interpretation | Incorrect when billing globally (professional + technical) |
| 26 | Professional component only physician interpretation of imaging performed elsewhere | Required when endocrinologist interprets study performed at another facility |
| GY | Service statutorily excluded from Medicare | For non-covered CGM services under Medicare when ABN not obtained |
| GA | ABN on file waiver of liability signed | Required when Medicare patient signs ABN for potentially denied service |
| 33 | Preventive service ACA first-dollar coverage | For ACA-covered preventive services with no patient cost-sharing |
| 95 | Synchronous telemedicine audio/video | Required for telehealth endocrinology visits; commercial payers |
| GT | Via interactive audio/video | Some Medicaid plans; verify by state |
Common Reasons Endocrinology Claims Get Denied And How We Fix Each One
1. Non-specific diabetes ICD-10 coding E11.9 used universally Using E11.9 for every Type 2 diabetes patient regardless of documented complications results in lower E/M level justification, inadequate medical necessity documentation for associated services, and missed specificity that payers use to evaluate claim validity.
Our fix: We review diabetes documentation against the full ICD-10 complication code set and apply the most specific code supported by the clinical note. Complication-specific codes (neuropathy, nephropathy, retinopathy, peripheral angiopathy) are captured consistently. Z79.4 is applied to all insulin-using Type 2 patients.
2. Missing Z79.4 on insulin-using Type 2 diabetes patients Type 2 diabetes patients on insulin require Z79.4 as a secondary code. Without it, CGM coverage criteria may not be met and insulin pump authorization may be denied.
Our fix: We cross-reference insulin use documentation with ICD-10 code selection on every diabetes claim. Z79.4 is applied systematically when insulin use is documented.
3. CGM and insulin pump supply billing not captured Ongoing CGM sensor, transmitter, and insulin pump supply billing is either entirely absent or submitted under incorrect HCPCS codes.
Our fix: We build a recurring supply billing workflow for active CGM and insulin pump patients, apply the correct HCPCS codes (A9276, A9277, A9278, K0553, A4224–A4232), and manage the prior authorization cycle for device and supply renewals.
4. E/M visits defaulting to 99213 for complex chronic disease visits Patients with diabetes complications, concurrent thyroid disease, and insulin pump management qualify for 99214 or 99215 but are routinely billed at 99213.
Our fix: We review E/M documentation against 2021 AMA MDM criteria and apply the code level the visit supports. Monthly E/M distribution analysis in reporting makes undercoding patterns visible and actionable.
5. DEXA denied for missing authorization or frequency violation DEXA claims are denied when prior authorization wasn’t obtained or the 24-month Medicare frequency rule is not tracked.
Our fix: We obtain authorization for all DEXA orders, track scan frequency per patient, and flag upcoming eligibility windows to prevent frequency denials.
6. Modifier 25 missing when procedure and E/M billed same day When a thyroid ultrasound, DEXA, or CGM setup is billed on the same date as an office visit, the E/M reimburses at zero without Modifier 25.
Our fix: Same-day service combinations are reviewed on every claim before submission. Modifier 25 is applied consistently whenever a separately identifiable E/M is documented on the same date as a procedure.
7. CGM professional interpretation (95251) not billed Endocrinologists regularly review and interpret CGM download data a separately billable professional service without submitting a claim for it.
Our fix: We identify CGM data interpretation sessions in the clinical workflow and bill 95251 with a supporting interpretation report when the documentation supports a separate service.
8. Thyroid FNA guidance code missing or incorrect Thyroid FNA with ultrasound guidance requires a specific CPT code (10005/10006) and documentation of permanent image recording. Billing 60100 (core needle biopsy) for an FNA, or missing the guidance code, results in underpayment.
Our fix: Thyroid biopsy claims are reviewed for procedure type, guidance use, and permanent image documentation before submission.
Our Endocrinology Billing Services Full Scope
Malakos Healthcare Solutions provides end-to-end revenue cycle management for endocrinology practices, diabetes care centers, and metabolic medicine clinics across the United States.
Eligibility & Benefit Verification We verify active coverage, deductibles, co-pays, authorization requirements, and device-specific benefit criteria including CGM and insulin pump coverage before every appointment and before every device order.
Prior Authorization Management We manage the full authorization lifecycle for CGM devices, insulin pumps, DEXA scans, thyroid imaging, specialty medications (GLP-1 agonists, SGLT-2 inhibitors, injectable osteoporosis agents), and high-value diagnostic panels. Authorization tracking is proactive with renewals initiated before current auths expire.
Endocrinology Specialty Coding Our coders apply the complete diabetes ICD-10 complication coding framework, CGM and insulin pump HCPCS codes, thyroid and adrenal procedure codes, and 2021 AMA E/M guidelines with endocrinology-specific MDM guidance on every claim, before submission.
CGM and Insulin Pump Billing Management We build and manage the recurring billing workflow for CGM and insulin pump patients device setup, ongoing supply billing, authorization renewals, and professional interpretation coding as a structured monthly revenue stream.
Claim Submission & Scrubbing Every charge is scrubbed against endocrinology-specific billing rules ICD-10 specificity, modifier completeness, same-day service conflicts, device HCPCS accuracy before electronic submission.
Denial Management We categorize every denial by root cause, appeal with supporting documentation, and fix upstream causes. Diabetes coding errors, CGM authorization gaps, and DEXA frequency denials each have distinct resolution workflows.
Accounts Receivable Follow-Up Structured 15/30/60-day AR cycle with direct payer outreach. No claim ages past 60 days without documented escalation.
Payment Posting & Underpayment Recovery Every EOB and ERA is reconciled against contracted rates. Device-related underpayments and CGM supply reimbursement variances are tracked and appealed.
Monthly Reporting & Practice Analytics Detailed monthly reports covering collections by service category, E/M level distribution, CGM/insulin pump billing performance, denial rates by CPT and payer, AR aging, and CCM billing capture. Full financial visibility across your endocrinology practice.
Why Endocrinology Practices Choose Malakos Healthcare Solutions
Diabetes coding depth. We apply the full ICD-10 diabetes complication framework not just E11.9 and capture Z79.4 systematically for insulin-using Type 2 patients. This single improvement increases E/M level justification accuracy and device coverage outcomes across your entire diabetes panel.
CGM and insulin pump billing infrastructure. We manage CGM and pump billing as a structured recurring revenue stream device codes, supply HCPCS, authorization renewal cycles, and professional interpretation billing not as an afterthought.
DEXA and imaging authorization management. High-value imaging services in endocrinology are lost most often to authorization gaps and frequency violations. We prevent both proactively.
E/M accuracy for chronic disease complexity. We apply 2021 AMA guidelines correctly to endocrinology visit complexity and provide E/M distribution analysis that makes undercoding patterns visible and correctable.
HIPAA-compliant operations. All data handling follows strict HIPAA protocols. A Business Associate Agreement (BAA) is included with every engagement.
Dedicated account manager. One contact who knows your payer mix, your patient population, and your billing history. No support queues.
No long-term contracts. We earn your business through results month to month from day one.
Frequently Asked Questions – Endocrinology Billing
Why is diabetes ICD-10 coding so important in endocrinology billing? Diabetes ICD-10 coding in endocrinology is not a single-code decision it requires selecting the primary diabetes type code plus any complication-specific codes (nephropathy, neuropathy, retinopathy, peripheral angiopathy) that are documented in the clinical record. Using E11.9 (unspecified) when complications are documented fails to capture the true complexity of the patient’s condition. This affects E/M level justification, medical necessity determinations for associated tests and devices, and in some cases payer authorization criteria for CGM and insulin pump therapy.
What is Z79.4 and when must it be used? Z79.4 (Long-term current use of insulin) is a required secondary ICD-10 code for any Type 2 diabetes patient who uses insulin. It is not required for Type 1 patients (insulin use is inherent in the Type 1 diagnosis). Failing to include Z79.4 when a Type 2 patient is insulin-treated is one of the most common ICD-10 errors in endocrinology. It can affect CGM coverage determinations and insulin pump authorization outcomes under Medicare and commercial plans.
Can endocrinologists bill for CGM data interpretation separately from the office visit? Yes. CPT 95251 covers ambulatory CGM interpretation and report as a distinct professional service. When a provider reviews CGM data outside of an office visit and documents a formal interpretation report, 95251 is separately billable. When CGM data review is incorporated into an office visit as part of the E/M service, the billing approach depends on payer-specific rules we verify and apply the correct approach by payer.
What makes DEXA scanning a compliance risk in endocrinology billing? Medicare covers axial DEXA every 24 months for qualifying patients. Billing DEXA more frequently than the coverage interval without documented medical exception is a Medicare compliance violation. Additionally, DEXA requires prior authorization from most commercial payers. We track DEXA frequency per patient and obtain authorization before every scan to prevent both compliance exposure and claim denials.
How does CCM billing apply to endocrinology practices? Chronic Care Management codes (99490 series) are billable for Medicare patients with two or more chronic conditions a description that applies to the majority of endocrinology patients (diabetes + hypothyroidism, diabetes + obesity, etc.). CCM requires written patient consent, a documented care plan, 24/7 access, and monthly time tracking. Most endocrinology practices have large qualifying CCM panels but no billing infrastructure to capture it. We build and manage that workflow as part of our standard service.
How quickly can we get started? Most endocrinology practices are fully onboarded within 7-14 business days. We begin with a free billing audit identifying CGM billing gaps, diabetes coding specificity issues, E/M undercoding patterns, and DEXA authorization workflows followed by a kickoff call to review your payer mix, EHR platform, and practice structure. Transition runs in parallel with no disruption to billing or cash flow.
Ready to Capture the Full Revenue Your Endocrinology Practice Earns?
If your practice is dealing with non-specific diabetes coding, uncaptured CGM billing, DEXA authorization denials, or E/M undercoding on complex chronic disease visits we can fix all of it.
A free billing audit will show you exactly where your practice is losing revenue and what the recovery opportunity looks like.
Schedule Your Free Billing Audit
📞 +1 (307) 441-3431 ✉️ support@malakoshcs.com
Malakos Healthcare Solutions | Endocrinology Billing Services USA | Serving endocrinology practices, diabetes care centers, and metabolic medicine clinics nationwide
